Line 665: |
Line 665: |
| : [[Oncocytic carcinoma]] | | : [[Oncocytic carcinoma]] |
| : [[Sebaceous carcinoma]] | | : [[Sebaceous carcinoma]] |
− | : Lipid-rich carcinoma | + | : [[Lipid-rich carcinoma]] |
− | : Glycogen-rich clear cell carcinoma | + | : [[Glycogen-rich clear cell carcinoma]] |
| : [[Acinic cell carcinoma]] | | : [[Acinic cell carcinoma]] |
| </div> | | </div> |
Line 676: |
Line 676: |
| '''Intraductal proliferative lesions''' | | '''Intraductal proliferative lesions''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | : [[Usual ductal hyperplasia]] | + | : Usual ductal hyperplasia |
− | : [[Columnar cell lesions]] | + | : Columnar cell lesions |
− | : [[Atypical ductal hyperplasia]] | + | : Atypical ductal hyperplasia |
| : [[Ductal carcinoma in situ]] | | : [[Ductal carcinoma in situ]] |
| </div> | | </div> |
Line 698: |
Line 698: |
| '''Benign epithelial proliferations''' | | '''Benign epithelial proliferations''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | : [[Adenosis, sclerosing adenosis and apocrine adenosis]] | + | : Adenosis, sclerosing adenosis and apocrine adenosis |
− | : [[Microglandular adenosis]],[[atypical microglandular adenosis]] and [[microglandular adenosis with carcinoma]] | + | : [[Microglandular adenosis]],[[atypical microglandular adenosis and microglandular adenosis with carcinoma]] |
| : [[Radial scar and complex sclerosing lesion]] | | : [[Radial scar and complex sclerosing lesion]] |
| : [[Tubular adenoma]] | | : [[Tubular adenoma]] |
− | : [[Lactating adenoma]] | + | : Lactating adenoma |
− | : [[Apocrine adenoma]] | + | : Apocrine adenoma |
− | : [[Ductal adenoma]] | + | : Ductal adenoma |
− | : [[Pleomorphic adenoma]] | + | : Pleomorphic adenoma |
| </div> | | </div> |
| </div> | | </div> |
Line 712: |
Line 712: |
| '''Myoepithelial and epithelial–myoepithelial lesions''' | | '''Myoepithelial and epithelial–myoepithelial lesions''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | : Myoepithelial and epithelial–myoepithelial lesions | + | : [[Myoepithelial and epithelial–myoepithelial lesions]] |
− | : Adenomyoepithelioma and adenomyoepithelioma with carcinoma | + | : [[Adenomyoepithelioma and adenomyoepithelioma with carcinoma]] |
| </div> | | </div> |
| </div> | | </div> |
Line 722: |
Line 722: |
| : Nodular fasciitis | | : Nodular fasciitis |
| : Benign vascular lesions | | : Benign vascular lesions |
− | : Pseudoangiomatous stromal hyperplasia | + | : [[Pseudoangiomatous stromal hyperplasia]] |
− | : Myofibroblastoma | + | : [[Myofibroblastoma]] |
− | : Desmoid-type fibromatosis | + | : [[Desmoid-type fibromatosis]] |
| : Inflammatory myofibroblastic tumour | | : Inflammatory myofibroblastic tumour |
| : Lipoma | | : Lipoma |
| : Granular cell tumour and benign peripheral | | : Granular cell tumour and benign peripheral |
| : nerve-sheath tumour | | : nerve-sheath tumour |
− | : Angiosarcoma | + | : [[Angiosarcoma]] |
| : Liposarcoma | | : Liposarcoma |
| : Rhabdomyosarcoma | | : Rhabdomyosarcoma |
Line 742: |
Line 742: |
| : [[Fibroadenoma]] | | : [[Fibroadenoma]] |
| : [[Phyllodes tumour]] | | : [[Phyllodes tumour]] |
− | : [[Hamartoma]] | + | : Hamartoma |
| </div> | | </div> |
| </div> | | </div> |
Line 749: |
Line 749: |
| '''Tumors of the nipple''' | | '''Tumors of the nipple''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | : [[Nipple adenoma]] | + | : Nipple adenoma |
| : Syringomatous tumour | | : Syringomatous tumour |
| : [[Paget disease]] | | : [[Paget disease]] |
Line 771: |
Line 771: |
| '''Tumors of the male breast''' | | '''Tumors of the male breast''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | : Gynaecomastia | + | : [[Gynaecomastia]] |
| : [[Carcinoma of the male breast]] | | : [[Carcinoma of the male breast]] |
| </div> | | </div> |
Line 780: |
Line 780: |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
| : Inherited syndromes associated with an increased risk of breast cancer: Introduction | | : Inherited syndromes associated with an increased risk of breast cancer: Introduction |
− | : BRCA1 and BRCA2 syndromes | + | : [[BRCA1 symdrome]] and [[BRCA2 syndrome]] |
− | : Li-Fraumeni syndrome | + | : [[Li-Fraumeni syndrome]] |
| : Ataxia telangiectasia syndrome | | : Ataxia telangiectasia syndrome |
| : Cowden syndrome | | : Cowden syndrome |